<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Journal of Advances in Medical and Biomedical Research</title>
<title_fa>Journal of Advances in Medical and Biomedical Research</title_fa>
<short_title>J Adv Med Biomed Res</short_title>
<subject>Medical Sciences</subject>
<web_url>http://journal.zums.ac.ir</web_url>
<journal_hbi_system_id>52</journal_hbi_system_id>
<journal_hbi_system_user>journal52</journal_hbi_system_user>
<journal_id_issn>1606-9366</journal_id_issn>
<journal_id_issn_online>2676-6264</journal_id_issn_online>
<journal_id_pii></journal_id_pii>
<journal_id_doi>10.30699/jambr</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid></journal_id_sid>
<journal_id_nlai></journal_id_nlai>
<journal_id_science></journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1396</year>
	<month>4</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2017</year>
	<month>7</month>
	<day>1</day>
</pubdate>
<volume>25</volume>
<number>112</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>fa</language>
	<article_id_doi></article_id_doi>
	<title_fa>بررسی پلی‌مورفیسم‌های A/C592- و A /G1082- ناحیه پروموتر ژن اینترلوکین 10 در  افراد مبتلا به دیابت نوع دو در شمال غرب ایران</title_fa>
	<title>Survey of Interleukin 10 Gene Promoter Polymorphisms at Position -592 (A/C) and -1082 (A/G) in Type 2 Diabetes Patients in Northwest Iran</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>کارآزمایی بالینی</content_type_fa>
	<content_type>Clinical Trials</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Background and Objective&lt;/em&gt;&lt;/strong&gt;&lt;strong&gt;&lt;em&gt;:&lt;/em&gt;&lt;/strong&gt; Today diabetes is one of the most prevalent noncontagious diseases around the world. There is strong evidence showing inflammatory reactions play a crucial role in initiating this disease. Interleukin 10 is one of the most significant anti-inflammatory cytokines. Thus the present study was conducted to investigate the relationship between Interleukin 10 gene polymorphisms -592 A/C and -1082 A/G and susceptibility to type 2 diabetes patients&lt;strong&gt; (&lt;/strong&gt;T2D).&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Materials and Methods: &lt;/em&gt;&lt;/strong&gt;In this study 75 T2D patients and 75 healthy controls were selected. DNA extraction was carried out and then the genotype in the -592 A/C and -1082A/G positions were determined using PCR-RFLP while chi squared (X&lt;sup&gt;2&lt;/sup&gt;) was used as the statistical method for data analysis.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Results:&lt;/em&gt;&lt;/strong&gt; The frequency of genotype AC and CC in the -592A/C position was significantly higher in type 2 diabetes patients compared to healthy controls (p&lt;0.05).&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;&lt;em&gt;Conclusions: &lt;/em&gt;&lt;/strong&gt;The high frequency of C allele in -592A/C can be considered as a predisposing factor for type 2 diabetes.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;&lt;p&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Key words: Type 2 diabetes, Polymorphism, Interleukin 10</keyword>
	<start_page>99</start_page>
	<end_page>107</end_page>
	<web_url>http://journal.zums.ac.ir/browse.php?a_code=A-10-4-1038&amp;slc_lang=fa&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Farzin</first_name>
	<middle_name></middle_name>
	<last_name>Ferdousi</last_name>
	<suffix></suffix>
	<first_name_fa>فرزین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>فردوسی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460053199</code>
	<orcid>5200319475328460053199</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Genetic, Biology Research Center, Zanjan Branch, Islamic Azad University, Zanjan, Iran</affiliation>
	<affiliation_fa>دانشگاه آزاد اسلامی، زنجان</affiliation_fa>
	 </author>


	<author>
	<first_name>Amir Hossein</first_name>
	<middle_name></middle_name>
	<last_name>Taromchi</last_name>
	<suffix></suffix>
	<first_name_fa>امیر حسین</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>تارمچی</last_name_fa>
	<suffix_fa></suffix_fa>
	<email>taromchi@zums.ac.ir</email>
	<code>5200319475328460053200</code>
	<orcid>5200319475328460053200</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Dept. of Biotechnology and Nanotechnology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
	<affiliation_fa>دانشکده‌ی پزشکی، دانشگاه علوم پزشکی زنجان، زنجان</affiliation_fa>
	 </author>


	<author>
	<first_name>Abdolreza</first_name>
	<middle_name></middle_name>
	<last_name>Esmaeilzadeh</last_name>
	<suffix></suffix>
	<first_name_fa>عبدالرضا</first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa>اسماعیل‌زاده</last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>5200319475328460053201</code>
	<orcid>5200319475328460053201</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>Dept. of Immunology, Faculty of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran</affiliation>
	<affiliation_fa>مرکز تحقیقات بیمارهای متابولیک، دانشگاه علوم پزشکی زنجان، زنجان</affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
